UnitedHealth Group Incorporated (NEO: UNH)
Canada
· Delayed Price · Currency is CAD 24.96
+0.38 (1.55%)
Jan 21, 2025, 3:56 PM EST
UnitedHealth Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 14,405 | 14,405 | 22,381 | 20,120 | 17,285 | 15,403 | Upgrade
|
| Depreciation & Amortization | 4,099 | 4,099 | 2,772 | 2,400 | 2,203 | 2,091 | Upgrade
|
| Other Amortization | - | - | 1,200 | 1,000 | 900 | 800 | Upgrade
|
| Gain (Loss) on Sale of Assets | 8,310 | 8,310 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 1,018 | 1,018 | 1,059 | 925 | 800 | 679 | Upgrade
|
| Change in Accounts Receivable | - | - | -3,114 | -2,523 | -1,000 | -688 | Upgrade
|
| Change in Accounts Payable | - | - | 3,516 | 1,964 | 1,162 | 5,348 | Upgrade
|
| Change in Unearned Revenue | - | - | 203 | 126 | -310 | 278 | Upgrade
|
| Change in Insurance Reserves / Liabilities | - | - | 3,482 | 4,053 | 2,701 | 152 | Upgrade
|
| Change in Other Net Operating Assets | -808 | -808 | -2,444 | -1,374 | -1,031 | -2,195 | Upgrade
|
| Other Operating Activities | -2,820 | -2,820 | 13 | -485 | -367 | 306 | Upgrade
|
| Operating Cash Flow | 24,204 | 24,204 | 29,068 | 26,206 | 22,343 | 22,174 | Upgrade
|
| Operating Cash Flow Growth | -16.73% | -16.73% | 10.92% | 17.29% | 0.76% | 20.10% | Upgrade
|
| Capital Expenditures | -3,499 | -3,499 | -3,386 | -2,802 | -2,454 | -2,051 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 685 | 3,414 | 15 | 221 | Upgrade
|
| Cash Acquisitions | -13,408 | -13,408 | -10,136 | -21,458 | -4,821 | -7,139 | Upgrade
|
| Investment in Securities | 525 | 525 | -1,777 | -6,837 | -1,843 | -2,836 | Upgrade
|
| Other Investing Activities | 374 | 374 | -960 | -793 | -1,269 | -727 | Upgrade
|
| Investing Cash Flow | -20,527 | -20,527 | -15,574 | -28,476 | -10,372 | -12,532 | Upgrade
|
| Short-Term Debt Issued | - | - | 11 | 732 | - | 872 | Upgrade
|
| Long-Term Debt Issued | 14,660 | 14,660 | 6,394 | 14,819 | 6,933 | 4,864 | Upgrade
|
| Total Debt Issued | 14,660 | 14,660 | 6,405 | 15,551 | 6,933 | 5,736 | Upgrade
|
| Total Debt Repaid | - | - | -2,125 | -3,015 | -4,452 | -3,150 | Upgrade
|
| Net Debt Issued (Repaid) | 14,660 | 14,660 | 4,280 | 12,536 | 2,481 | 2,586 | Upgrade
|
| Issuance of Common Stock | - | - | 1,353 | 1,253 | 1,355 | 1,440 | Upgrade
|
| Repurchases of Common Stock | -9,000 | -9,000 | -8,000 | -7,000 | -5,000 | -4,250 | Upgrade
|
| Common Dividends Paid | -7,533 | -7,533 | -6,761 | -5,991 | -5,280 | -4,584 | Upgrade
|
| Other Financing Activities | -1,639 | -1,639 | -2,401 | 3,428 | -1,011 | 1,218 | Upgrade
|
| Financing Cash Flow | -3,512 | -3,512 | -11,529 | 4,226 | -7,455 | -3,590 | Upgrade
|
| Foreign Exchange Rate Adjustments | -61 | -61 | 97 | 34 | -62 | -116 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -219 | -219 | - | - | - | - | Upgrade
|
| Net Cash Flow | -115 | -115 | 2,062 | 1,990 | 4,454 | 5,936 | Upgrade
|
| Free Cash Flow | 20,705 | 20,705 | 25,682 | 23,404 | 19,889 | 20,123 | Upgrade
|
| Free Cash Flow Growth | -19.38% | -19.38% | 9.73% | 17.67% | -1.16% | 22.76% | Upgrade
|
| Free Cash Flow Margin | 5.17% | 5.17% | 6.91% | 7.22% | 6.92% | 7.83% | Upgrade
|
| Free Cash Flow Per Share | 22.29 | 22.29 | 27.38 | 24.64 | 20.80 | 20.94 | Upgrade
|
| Cash Interest Paid | - | - | 3,035 | 1,945 | 1,653 | 1,704 | Upgrade
|
| Cash Income Tax Paid | - | - | 6,078 | 5,222 | 3,966 | 4,935 | Upgrade
|
| Levered Free Cash Flow | 13,626 | 13,626 | 19,817 | 23,759 | 19,251 | 20,024 | Upgrade
|
| Unlevered Free Cash Flow | 16,067 | 16,067 | 21,846 | 25,067 | 20,288 | 21,063 | Upgrade
|
| Change in Net Working Capital | 5,730 | 5,730 | 23 | -5,772 | -3,858 | -5,541 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.